Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Antibe Therapeutics Inc(Pre-Merger) T.ATE

Alternate Symbol(s):  ATBPF

Antibe Therapeutics Inc. is a clinical-stage biotechnology company. The Company is leveraging its hydrogen sulfide (H2S) platform to develop therapies to target inflammation arising from a range of medical conditions. The Company’s pipeline includes assets that seek to overcome the gastrointestinal ulcers and bleeding associated with nonsteroidal anti-inflammatory drugs (NSAIDs). Its lead drug, otenaproxesul, is in clinical development as an alternative to opioids and NSAIDs for acute pain. Its second pipeline drug, ATB-352, is being developed for a specialized pain indication. The Company also focuses on inflammatory bowel disease (IBD). Otenaproxesul combines a moiety that releases hydrogen sulfide with naproxen, a non-steroidal, anti-inflammatory drug. ATB-352 is an H2S-releasing derivative of ketoprofen, a potent NSAID commonly prescribed for acute pain. Its IBD candidates are being designed to maintain the efficacy, safety, and pharmacokinetic properties of ATB-429.


TSX:ATE - Post by User

Post by TriumphSpitSixon Nov 05, 2020 3:57pm
168 Views
Post# 31846118

OT- Big mover to check out while Antibe languishes...

OT- Big mover to check out while Antibe languishes...Interested in Oil & Gas?

CSE-listed Micromem Technologies (C.MRM) today had an intraday pop from 4 to 60 (!) cents then back down to 6 cents. No idea what happened there but the company is finalizing a deal with Romanian state-owned natural gas company Romgaz for the use of Micromem's AROMA Tracer oil and gas well analytics sensors which could be significant in terms of units and dollar amount. They have also been working through tests and trials with Chevron for the past few years and a deal is also expected with that O&G giant.

This company is a true sleeper. I've made multi-baggers on it more than once in the past few years all while the message board is essentially dead. Evidently no one knows about them but they are on the verge of multiple deals worth probably tens-of-millions-of-dollars or more each.

Another SP rally is brewing right now. It's up almost 100% since just Tuesday.
<< Previous
Bullboard Posts
Next >>